Your browser doesn't support javascript.
loading
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project.
Mikkelsen, Christina; Mori, Gaia; van Walraven, Suzanna M; Castrén, Johanna; Zahra, Sharon; MacLennan, Sheila; Seidel, Kirsten; Fontana, Stefano; Veropalumbo, Eva; Cannata, Livia; Pupella, Simonetta; Kvist, Maria; Happel, Marjan; Korkalainen, Piia; Chandrasekar, Akila; Paulus, Ulrike; Bokhorst, Arlinke; Wulff, Birgit; Fernandez-Sojo, Jesus; Eguizabal, Cristina; Urbano, Fernando; Vesga, Miguel Angel; van Kraaij, Marian; Merz, Eva-Maria; van den Hurk, Katja; Hansen, Morten Bagge; Slot, Ed; Ullum, Henrik.
Affiliation
  • Mikkelsen C; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Mori G; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • van Walraven SM; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Castrén J; Finnish Red Cross, Blood Service, Helsinki, Finland.
  • Zahra S; Scottish National Blood Transfusion Service, Edinburgh, Scotland.
  • MacLennan S; National Health Service Blood and Transplant, UK.
  • Seidel K; CSL Plasma GmbH, Marburg, Germany.
  • Fontana S; Interregional Blood Transfusion Service SRC, University of Lausanne, Berne, Switzerland.
  • Veropalumbo E; Centro Nazionale Sangue, Istituto Superiore di Sanità, Rome, Italy.
  • Cannata L; Centro Nazionale Sangue, Istituto Superiore di Sanità, Rome, Italy.
  • Pupella S; Centro Nazionale Sangue, Istituto Superiore di Sanità, Rome, Italy.
  • Kvist M; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Solna, Sweden.
  • Happel M; TRIP Hemovigilance and Biovigilance Office, Leiden, the Netherlands.
  • Korkalainen P; Finnish Red Cross, Blood Service, Helsinki, Finland.
  • Chandrasekar A; National Health Service Blood and Transplant, UK.
  • Paulus U; National Health Service Blood and Transplant, UK.
  • Bokhorst A; TRIP Hemovigilance and Biovigilance Office, Leiden, the Netherlands.
  • Wulff B; Institute of Legal Medicine, University Medical Center Hamburg, Hamburg, Germany.
  • Fernandez-Sojo J; Banc de Sang I Teixits, Barcelona, Spain.
  • Eguizabal C; Bioef-Fundacion Vasca de Innovacion e Investigation Sanitarias-Osakidetza-Centro Vasco de Transfusión y Tejidos Humanos, Galdakao, Spain.
  • Urbano F; Bioef-Fundacion Vasca de Innovacion e Investigation Sanitarias-Osakidetza-Centro Vasco de Transfusión y Tejidos Humanos, Galdakao, Spain.
  • Vesga MA; Bioef-Fundacion Vasca de Innovacion e Investigation Sanitarias-Osakidetza-Centro Vasco de Transfusión y Tejidos Humanos, Galdakao, Spain.
  • van Kraaij M; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Merz EM; Sanquin Research, Department of Donor Medicine Research - Donor Studies, Amsterdam, the Netherlands.
  • van den Hurk K; Department of Sociology, Vrije Universiteit, Amsterdam, the Netherlands.
  • Hansen MB; Sanquin Research, Department of Donor Medicine Research - Donor Studies, Amsterdam, the Netherlands.
  • Slot E; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ullum H; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
Vox Sang ; 116(3): 342-350, 2021 Mar.
Article de En | MEDLINE | ID: mdl-33191514
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Donor selection criteria (DSC) are a vital link in the chain of supply of Substances of Human Origin (SoHO) but are also subject to controversy and differences of opinion. Traditionally, DSC have been based on application of the precautionary principle. MATERIALS AND

METHODS:

From 2017 to 2020, TRANSPOSE (TRANSfusion and transplantation PrOtection and SElection of donors), a European research project, aimed to identify discrepancies between current DSC by proposing a standardized risk assessment method for all SoHO (solid organs excluded) and all levels of evidence.

RESULTS:

The current DSC were assessed using a modified risk assessment method based on the Alliance of Blood Operators' Risk-based decision-making framework for blood safety. It was found that with limited or diverging scientific evidence, it was difficult to reach consensus and an international standardized method for decision-making was lacking. Furthermore, participants found it hard to disregard their local guidelines when providing expert opinion, which resulted in substantial influence on the consensus-based decision-making process.

CONCLUSIONS:

While the field of donation-safety research is expanding rapidly, there is an urgent need to formalize the decision-making process regarding DSC. This includes the need for standardized methods to increase transparency in the international decision-making process and to ensure that this is performed consistently. Our framework provides an easy-to-implement approach for standardizing risk assessments, especially in the context of limited scientific evidence.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Donneurs de sang / Sélection de donneurs / Sécurité transfusionnelle Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Vox Sang Année: 2021 Type de document: Article Pays d'affiliation: Danemark

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Donneurs de sang / Sélection de donneurs / Sécurité transfusionnelle Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Vox Sang Année: 2021 Type de document: Article Pays d'affiliation: Danemark
...